deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03115268

Delivering Group Support for People With Aphasia Through Eva Park

Sponsor: City, University of London

Conditions Aphasia
Updated 8 times since 2017 Last updated: Aug 5, 2019 Started: May 16, 2017 Primary completion: Nov 30, 2018 Completion: Apr 15, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03115268, this NA trial focuses on Aphasia and remains completed. Sponsored by City, University of London, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~May 2017 – ~Aug 2017 · 3 months · monthly snapshotRecruiting~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotRecruiting~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotRecruiting~Aug 2018 – ~Sep 2019 · 13 months · monthly snapshotActive Not Recruiting~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Sep 2019 — Jan 2021 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

  5. Aug 2018 — Sep 2019 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

Show 3 earlier versions
  1. Jun 2018 — Aug 2018 [monthly]

    Recruiting NA

  2. Aug 2017 — Jun 2018 [monthly]

    Recruiting NA

  3. May 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • City, University of London
  • The Stroke Association, United Kingdom
Data source: City, University of London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations